From Casetext: Smarter Legal Research

Ivie v. Kraft Foods Global, Inc.

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA SAN JOSE DIVISION
Feb 25, 2013
Case No. C-12-02554-RMW (N.D. Cal. Feb. 25, 2013)

Summary

holding that evaporated cane juice claims were not expressly preempted because "the FDA has [] articulated a policy position"

Summary of this case from Werdebaugh v. Growers

Opinion

Case No. C-12-02554-RMW

02-25-2013

SUSAN IVIE, individually and on behalf of all others similarly situated, Plaintiff, v. KRAFT FOODS GLOBAL, INC., CADBURY ADAMS USA LLC, and BACK TO NATURE FOOD COMPANY, Defendants.


ORDER GRANTING-IN-PART AND

DENYING-IN-PART DEFENDANTS'

MOTION TO DISMISS COMPLAINT


[Re Docket No. 31]

Plaintiff sued defendants Kraft Foods Global, Inc., Cadbury Adams USA LLC, and Back to Nature Food Company (collectively "defendants") under California's unfair completion law Cal. Bus. & Prof. Code §§ 17200 et seq. ("UCL") (counts 1-3), fair advertising law, id. § 17500 et seq. ("FAL") (counts 4-5), and Consumer Legal Remedies Act, Cal. Civ. Code § 1750, et seq. ("CLRA") (count 6); for restitution based on unjust enrichment (count 7); and under California's Song-Beverly Consumer Warranty Act (count 8) and the federal Magnuson-Moss Warranty Act (count 9). The laws alleged to be violated as a predicate for the "unlawful" prong of plaintiffs' UCL claim include provisions of the state Sherman Food, Drug, and Cosmetic Laws ("Sherman Laws") and California Health & Safety Code § 109875 et seq. Defendants move to dismiss all counts for failure to state a claim. Having considered the arguments of the parties, and for the reasons set forth below, this court GRANTS-IN-PART and DENIES-IN-PART defendants' motion to dismiss.

I. BACKGROUND

A. Statutory and Regulatory Framework

In 1938, Congress enacted the Federal Food, Drug, and Cosmetic Act ("FDCA"), codified at 21 U.S.C. § 301 et seq., "The [FDCA] gives the [United States Food and Drug Administration ("FDA")] the responsibility to protect the public health by ensuring that 'foods are safe, wholesome, sanitary, and properly labeled,' 21 U.S.C. § 393(b)(2)(A), and the FDA has promulgated regulations pursuant to this authority, see, e.g., 21 C.F.R. § 101.1 et seq." Lockwood v. Conagra Foods, Inc., 597 F. Supp. 2d 1028, 1030 (N.D. Cal. 2009). "There is no private right of action under the FDCA." Id. (citing Merrell Dow Pharms., Inc. v. Thompson, 478 U.S. 804, 810 (1986)). Rather, "the FDA enforces the FDCA and its regulations through administrative proceedings." Id.

In 1990, Congress enacted the Nutrition Labeling and Education Act ("NLEA"), codified in scattered sections of 21 U.S.C., amending the FDCA. "The NLEA aimed to 'clarify and . . . strengthen the [FDA's] authority to require nutrition labeling on foods, and to establish the circumstances under which claims may be made about nutrients in foods.'" Chacanaca v. Quaker Oats Co., 752 F. Supp. 2d 1111, 1116 (N.D. Cal. 2010) (quoting H.R. Rep. No. 101-538, at 7 (1990), reprinted in 1990 U.S.C.C.A.N. 3336, 3337). For example, 21 U.S.C. § 343 provides that a "food shall be deemed misbranded" if, inter alia, it contains a "false or misleading label," § 343(a); if information required on the label is "not prominently placed" on the label in comparison with other words, § 343(f); if it "bears or contains any artificial flavoring, artificial coloring, or chemical preservative" without "bear[ing] labeling stating that fact," § 343(k); if it does not properly identify nutrition information, for example, serving size, number of servings, calories, and certain nutrients, § 343(q); or if it contains improper "nutrition levels and health related claims," § 343(r) ("nutrient content claims").

The NLEA also "amended the FDCA by adding [21 U.S.C. § 343-1(a),] an express preemption provision." Lockwood, 597 F. Supp. 2d at 1030. Section 343-1(a) provides in relevant part that:

[N]o State or political subdivision of a State may directly or indirectly establish under any authority or continue in effect as to any food in interstate commerce--
. . .
(3) any requirement for the labeling of food of the type required by section . . . 343(d) [misleading container], 343(f) [prominence of information on label], 343(h) [representations as to standards of quality and fill of container], . . . or 343(k) [artificial flavoring, artificial coloring, or chemical preservatives] of this title that is not identical to the requirement of such section
. . .
(4) any requirement for nutrition labeling of food that is not identical to the requirement of section 343(q) [nutrition information] of this title
. . .
(5) any requirement respecting any claim of the type described in section 343(r)(1) [nutrient content claims] of this title, made in the label or labeling of food that is not identical to the requirement of section 343(r) of this title . . . .
21 U.S.C. § 343-1(a)(3)-(5) (emphases added). The express preemption provisions "reach[] beyond positive enactments like statutes and regulations, to embrace common-law duties and judge-made rules." Chacanaca, 752 F. Supp. 2d at 1118 (citing Bates v. Dow Agrosciences, LLC, 544 U.S. 431, 443 (2005)). The NLEA, however, does not "preempt any provision of State law" not "expressly preempted under [21 U.S.C. § 343-1(a)]." Id. (quoting Pub. L. No. 101-535, § 6(c)(1), 104 Stat. 2353, 2364).

B. California State Laws

California's Sherman Laws adopt the federal labeling requirements as the food labeling requirements of the state. Cal. Health & Safety Code § 110100 ("All food labeling regulations and any amendments to those regulations adopted pursuant to the federal act, in effect on January 1, 1993, or adopted on or after that date shall be the food regulations of this state."). In addition to this blanket provision, the Sherman Laws specifically adopted certain provisions that mirror or incorporate by reference the FDCA and NLEA food labeling and packing requirements, including the following provisions that, inter alia, form the basis for the "unlawful" prong of plaintiff's UCL claim:

Any food is misbranded if its labeling is false or misleading in any particular, id. § 110660;
Any food is misbranded if its labeling does not conform with the requirements for nutrition labeling set forth in Section 403(q) (21 U.S.C. Sec. 343(q)) of the federal act and the regulations adopted pursuant thereto, id. § 110665 (emphasis added);
Any food is misbranded if its labeling does not conform with the requirements for nutrient content or health claims set forth in Section 403(r) (21 U.S.C. Sec. 343(r)) of the federal act and the regulations adopted pursuant thereto, id. § 110670 (emphasis added);
Any food is misbranded if any word, statement, or other information required pursuant to this part to appear on the label or labeling is not prominently placed upon the label or labeling with conspicuousness, as compared with other words, statements, designs, or devices in the labeling and in terms as to render it likely to be read and understood by the ordinary individual under customary conditions of purchase and use, id. § 110705;
Any food is misbranded if it purports to be, or is represented, for special dietary uses . . . and its label does not bear information concerning any vitamin or mineral content, or other dietary property as the department prescribes, by regulation, as necessary to fully inform purchasers as to the food's value for that use, id. § 110735; and
Any food is misbranded if it bears or contains any artificial flavoring, artificial coloring, or chemical preservative, unless its labeling states that fact. Exemptions may be established by the department, id. § 110740.
See Amended Complaint ("AC") ¶¶ 52, 198-218.

C. The Products and Labels at Issue

The plaintiff's claims are based on allegedly unlawful and misleading labels or packaging on a variety of defendants' consumer food products, including gum, crackers, granola, fruit punch, cheese, nut mix, lemonade, stuffing mix, Jell-O, and Easy Mac. See AC ¶ 223. The plaintiff alleges that the following representations on the product packaging or product websites were unlawful and misleading in violation of the Sherman Laws: (1) "natural" or "all natural" claims; (2) "no artificial" colors/sweeteners/flavors/preservatives/ingredients claims; (3) nutrient content claims; (4) health claims; (5) "sugar free" or "sugarless" claims; (6) stated serving sizes; and (7) "evaporated cane juice" claims. Opp. Br. 3, Dkt. No. 39. Plaintiff alleges that she "read the labels," and was "misled . . . with respect to the nature, nutritional content and healthiness of the products she was purchasing." Id. ¶ 225. Plaintiff further alleges that she "based and justified the decision to purchase [d]efendants' products in substantial part on [d]efendants' package labeling, packaging and website claims," and "would have foregone purchasing [d]efendants' products and bought other products readily available at a lower price." Id. ¶226.

The claims are also based on certain products that plaintiff did not purchase but bearing similar labels to those products that she purchased, including Back to Nature Classic Cream Cookes, Fudge Mint Cookies, and Fudge Striped Cookies ("no artificial flavors or preservatives" claims), id. ¶87; Halls Refresh Sugar Free Drops, id. ¶ 150 ("sugar free" claims); and (4) Trident White Spearmint Sugar Free Gum, id. ¶151 ("sugar free" claims).

II. ANALYSIS

A. Legal Standard

"After the pleadings are closed[,] . . . a party may move for judgment on the pleadings." Fed. R. Civ. P. 12(c). When considering a motion for judgment on the pleadings, the court takes all factual allegations in the complaint as true and construes them in a light most favorable to the plaintiff. Sateriale v. R.J. Reynolds Tobacco Co., 697 F.3d 777, 783 (9th Cir. 2012). To survive a motion to dismiss for failure to state a claim, the facts pled need only give rise to "a claim to relief that is plausible on its face." Bell Atl. Corp. v. Twombly, 550 U.S. 544, 570 (2007). "However, this principle is innaplicable to legal conclusions; 'threadbare recitals of the elements of a cause of action, supported by mere conclusory statements,' are not taken as true." Delacruz v. Cytosport, Inc., No 11-3532, 2012 WL 2563857, *5 (N.D. Cal. June 28, 2012) (quoting Ashcroft v. Iqbal, 556 U.S. 662, 663 (2009).

B. Judicial Notice

The court takes judicial notice of exhibits 1-25, filed by defendants in support of this motion. Dkt. 33. Exhibits 1-21 depict the packaging of the products plaintiff challenged in the AC. Exhibits 22-23 portray unchallenged product packaging bearing similar labels to the challenged products, where the images are available on the internet. Exhibits 24 and 25 are publicly available FDA publications on the FDA website.

The court also takes judicial notice of exhibit A, filed by defendant in support of their reply brief, which is a picture of the Kraft Mexican Style Four Cheese package at issue in the AC. Dkt. 45-1.

C. Standing under the UCL, FAL and CLRA

Article III standing, for purposes of a motion to dismiss, requires a plaintiff to plead "injury in fact," "a causal connection between the injury and the conduct complained of," and a likelihood that the injury will be redressed by a favorable decision. Lujan v. Defenders of Wildlife, 504 U.S. 555, 561 (1992). In particular, the injury must be "an invasion of a legally protected interest which is (a) concrete and particularized and (b) actual or imminent, not conjectural or hypothetical." Id. (interal quotation marks omitted).

California's UCL and FAL incorporate Article III standing requirements, and additionally require that the plaintiff plead an economic injury. Kwikset Corp. v. Super. Ct., 51 Cal. 4th 310, 322-23 (2011); see also TrafficSchool.com, Inc. v. Edriver Inc., 653 F.3d 820, 825 n.1 (9th Cir. 2011) ("Plaintiffs filing an unfair competition suit must prove a pecuniary injury . . . and 'immediate' causation. . . . Neither is required for Article III standing." (internal citations omitted)). Under the UCL and FAL, "a plaintiff suffers 'injury in fact' . . . when he or she has: (1) expended money due to the defendants' acts of unfair competition; (2) lost money or property; or (3) been denied money to which he or she has a cognizable claim." Chacanaca, 752 F. Supp. 2d at 1125. To satisfy the injury-in-fact requirement for unfair competition claims, "courts in California require that plaintiffs demonstrate the purchase of products as a result of deceptive advertising." Id. (citing Laster v. T-Mobile USA, Inc., 407 F. Supp. 2d 1181, 1194 (S.D. Cal. 2005)).

1. Whether plaintiff suffered cognizable injury

Defendants allege that plaintiff suffered no injury-in-fact because "[p]laintiff's alleged harm is not real harm; it is merely a legal construct. Plaintiff paid for gum and nuts and sweet beverages. The goods were not tainted, spoiled, adulterated, or contaminated. . . . And Plaintiff consumed the products without incident or physical injury." Mot. 29, Dkt. No. 31. Here, defendants' argument misses the mark, because plaintiff's injury is based on the allegation that she would not have purchased the product if she had known that the labels were unlawful. The alleged purchase of a product that plaintiff would not otherwise have purchased but for the alleged unlawful label is sufficient to establish an economic injury-in-fact for plaintiff's unfair competition claims. See Chacanaca, 752 F. Supp. 2d at 1125; Chaves v. Blue Sky Natural Beverage Co., 340 Fed. App'x 359, 360-61 (9th Cir. 2009); Kashin v. Hershey Co., 2012 WL 5471153, at *6 (N.D. Cal. Nov. 9, 2012); Carrea v. Dreyer's Grand Ice Cream, Inc., 2011 WL 159381, at *2-3 (N.D. Cal. Jan. 10, 2011). To the extent the injury alleged is reliance on misleading, as opposed to unlawful, labels, whether plaintiff was actually misled is a factual question that is an inappropriate basis for dismissal at this stage. See Kashin, 2012 WL 5471153, at *7 ("[T]he issues Defendant raise ultimately involve questions of fact as to whether Plaintiff was or was not deceived by the labeling; this argument is . . . beyond the scope of this Rule 12 (b)(6) motion."); Astiana v. Ben & Jerry's Homemade, Inc. ("Ben & Jerry's"),2011 WL 2111796, *4 (N.D. Cal. May 26, 2011) (same).

2. Products plaintiff did not purchase

Defendants further argue that plaintiff lacks standing to sue based on products that she did not herself purchase. Although courts are split as to whether actual purchase is required to establish the requisite injury-in-fact, see Miller v. Ghirardelli Chocolate Co., 2012 WL 6096593, at *6-7 (N.D. Cal. Dec. 7, 2012) (recognizing split and analyzing cases), in this case, the court agrees with defendants that there can be no requisite pecuniary injury where plaintiff did not herself purchase the product at issue. The alleged injury in this case is that plaintiff "based and justified the decision to purchase [d]efendants' products in substantial part on [d]efendants' package labeling, packaging and website claims" and "would have foregone purchasing [d]efendants' products and bought other products readily available at a lower price." AC ¶ 226 (emphases added). See Granfield v. NVIDIA Corp., 2012 WL 2847575, at *6 (N.D. Cal. July 11, 2012) ("[C]laims related to products not purchased must be dismissed for lack of standing."); Larsen v. Trader Joe's Co., 2012 WL 5458396, at *5 (N.D. Cal. June 14, 2012) (same); Mlejnecky v. Olympus Imaging Am. Inc., 2011 WL 1497096, at *4 (E.D. Cal. Apr. 19, 2011) (same); Carrea v. Dreyer's Grand Ice Cream, Inc., 2011 WL 159380, at *3 (N.D. Cal. Jan. 10, 2011) (same); Johns v. Bayer Corp., 2010 WL 476688, at *5 (S.D. Cal. Feb. 9, 2010) ("[P]laintiff cannot expand the scope of h[er] claims to include a product [s]he did not purchase or advertisements relating to a product that [s]he did not rely upon."). The court dismisses all claims related to products plaintiff did not herself purchase, with leave to amend.

D. Primary jurisdiction doctrine

"The primary jurisdiction doctrine allows courts to stay proceedings or to dismiss a complaint without prejudice pending the resolution of an issue within the special competence of an administrative agency." Clark v. Time Warner Cable, 523 F.3d 1110, 1114 (9th Cir. 2008). The doctrine "is committed to the sound discretion of the court when 'protection of the integrity of a regulatory scheme dictates preliminary resort to the agency which administers the scheme.'" Syntek Semiconductor Co. v. Microchip Tech. Inc., 307 F.3d 775, (9th Cir. 2002) (quoting United States v. General Dynamics Corp., 828 F.2d 1356, 1362 (9th Cir. 1987)). Courts consider the following non-exaustive factors in deciding whether the doctrine of primary jurisdiction applies: "(1) the need to resolve an issue that (2) has been placed by Congress within the jurisdiction of an administrative body having regulatory authority (3) pursuant to a statute that subjects an industry or activity to a comprehensive regulatory authority that (4) requires expertise or uniformity in administration." Id. The doctrine "is to be used only if a claim 'requires resolution of an issue of first impression, or of a particularly complicated issue that Congress has committed to a regulatory agency." Time Warner, 523 F.3d at 1114 (quoting Brown v. MCI WorldCom Network Servs., 277 F.3d 1166, 1172 (9th Cir. 2002)).

Defendants first argue that plaintiff's claims are mere attempts to privately enforce provisions of the FDCA and NLEA, federal acts whose enforcement is within the express jurisdiction of the FDA. Defendants rely primarily on the Ninth Circuit Court of Appeal's decision in Pom Wonderful LLC v. Coca-Cola Co., 679 F.3d 1170 (9th Cir. 2012), where the court of appeals dismissed federal Lanham act claims implicitly on the basis of primary jurisdiction with the FDA. In Pom, a juice manufacturer, Pom Wonderful, brought claims against Coca-Cola under the Lanham Act and under California's UCL and FAL for unfair competition and false advertising based on the alleged use of a deceptive name and label for its juice product. 679 F.3d at 1176. The Ninth Circuit found that Coca-Cola's product name and labeling, to the best the court could tell, complied with the FDCA, and thus allowing Pom to proceed with the Lanham Act claim would "undermine the FDA's regulations and expert judgments." Id. at 1176-77 ("If the FDA believes that more should be done to prevent deception, or that Coca-Cola's label misleads consumers, it can act. But, under our precedent, for a court to act when the FDA has not—despite regulating extensively in this area—would risk undercutting the FDA's expert judgments and authority."). To the extent Coca-Cola's compliance was unclear, the court held that it is impermissible for the "court originally to interpret ambiguous FDA regulations, because rendering such an interpretation would usurp the FDA's interprative authority." Id. at 1176. The court of appeals, however, did not resolve Pom's state law UCL and FAL claims, and remanded those claims to the district court to rule on standing. Id. at 1178-79.

Defendants argue that Pom's holding is equally applicable to plaintiff's state law claims here because, just like Pom's claims under the Lanham Act , "allowing such a suit [under the UCL, FAL or CLRA] would undermine Congress's decision to limit enforcement of the FDCA to the federal government.'" Mot. 5 (quoting Pom, 679 F.3d at 1176). In Astiana v. Hain Celestial Grp. ("Hain Celestial"),--F. Supp. 2d --, 2012 WL 5873585 (N.D. Cal. Nov. 19, 2012), this court recently extended the court of appeal's reasoning in Pom to state law unfair competition claims. In Hain Celestial, the issue was whether the defendant's cosmetic products bearing the terms "all natural," "pure natural," and "pure, natural, and organic" were false and misleading for the purposes of state law UCL, FAL and CLRA claims. Id. at *1. The Hain Celestial court relied on Pom Wonderful, holding that:

In the absence of any FDA rules or regulations (or even informal policy statements) regarding the use of the word "natural" on cosmetics labels, the court declines to make any independent determination of whether defendants' use of "natural" was false or misleading. Doing so would 'risk undercutting the FDA's expert judgments and authority.' Pom at 1177. Thus, the court finds that plaintiff's claims are barred under the primary jurisdiction doctrine.
Hain Celestial, 2012 WL 5873585, *3. Thus, where the FDA has yet to speak on whether a particular label or claim on a consumer product is unlawful or misleading, it may be appropriate to dismiss a plaintiff's state law unfair competition claims based on that particular label or claim under the primary jurisdiciton doctrine. See id. In contrast, however, where FDA policy is clearly established with respect to what constitutes an unlawful or misleading label, the primary jurisdiction doctrine is inapplicable because there is little risk that the courts will undermine the FDA's expertise. See id. at *1 (explaining that courts "regularly decide whether conduct is false or misleading" when such a decision would not "'undermin[e], through private litigation, the FDA's considered judgments'" (quoting Pom Wonderful, 679 F.3d at 1178)).

Here, the primary jurisdiction doctrine is inapplicable to the vast majority of plaintiff's state UCL, FAL and CLRA claims, which, as explained infra, are predicated on California state law violations that mirror or are identical to FDA provisions which require no original interpretation by this court. See Part II.E infra (explaining that the FDA policy is already known with respect to the majority of the alleged unlawful or misleading labels).

With respect to the "one mint" serving size claims, however, the FDA is currently engaged in rulemaking procedures to change its existing requirements for breath mints, and thus the doctrine of primary jurisdiction is appropriate. Plaintiff alleges that she relied on unlawful and deceptive labels in purchasing Dentyne breath mint packages containing a "one mint" serving size claim. According to plaintiff, the serving size should be stated as two grams (four mints), and not 0.5 grams (one mint), based on a 1993 regulation providing a "reference amount" (i.e., "Reference Amounts Customarily Consumed Per Eating Occasssion" ("RACC")) of two grams for hard candies and breath mints. 21 C.F.R. § 101.12(b); 58 Fed. Reg. 2229, 2297 (Jan. 6, 1993). In 1997, however, the FDA proposed a regulation (the "1997 proposal") to change the RACC for small breath mints because that "the data suggest[ed] that serving sizes near 2 g are too large for small breath mint products." 62 Fed. Reg. 67775, 67776 (proposed Dec. 30, 1997). Because the data showed that small breath mints, like those at issue here, are "designed to be consumed singly or in small numbers, and that consumers do in fact, limit their consumption to such amounts," the FDA propsed requiring the serving size on the label of all breath mints to be declared as one mint to more accurately reflect consumption across the broad spectrum of breath mint sizes . . . " Id. The FDA heard notice and comments on the 1997 proposal in 2005, and in February 2012, included the proposed rule on its regulatory agenda for the year. Dept. of Health & Human Servs., Regulatory Agenda, 77 Fed. Reg. 7946-01, 7955 (Feb. 13, 2012). Because the FDA is currently in the process of amending its serving size regulations with respect to small breath mints, which includes those at issue here, the court declines to usurp the FDA's expertise in this area. See Taradejna v. General Mills, Inc., ---F. Supp. 2d ---, 2012 WL 6113146, at *5 (D. Minn. 2012) (dismissing a claim under the primary jurisdiciton doctrine because, "given that the FDA has issued its 2009 Proposed Rule on the standard of identity for yogurt, it would be imprudent for the Court, at this juncture, to substitute its judgment for that of the Agency's while revision of the standard of identity is pending."); Gordon v. Church & Dwight Co., 2010 WL 1341184, at *2 (N.D. Cal. Apr. 2, 2010) (dismissing UCL, FAL and CLRA claims where, inter alia, "the FDA has stated that it is still considering public comments and other data in connection with warnings similar to those that plaintiffs seek to have the court impose"). The court dismisses plaintiff's state law claims based on "one mint" serving size labels under the primary jurisdiction doctrine.

E. Express preemption

Defendants also argue that the plaintiff's claims are preempted under 21 U.S.C. § 343-1, the FDCA's express preemption provision. According to defendants, because each and every food label at issue is in compliance with federal law, a judgment in plaintiff's favor would impose different or additional requirements than those of the FDCA and NLEA, and thus express preemption applies. Plaintiff counters that each and every label or package at issue actually violates exisiting FDA policies, and thus, plaintiff seeks to impose nothing more than what the FDA already requires.

Here, plaintiff's state UCL, FAL and CLRA claims are predicated not on the FDCA or NLEA, but rather on California's Sherman Laws, including California Health & Safety Code §§ 110100, 110660, 110665, 110670, 110705, 110735, and 110740, which as discussed above, mirror or incorporate the relevant FDCA and NLEA provisions and implementing regulations by reference. California courts generally hold that there is no bar to bring suits to enforce California laws. See, e.g., Kashin, 2012 WL 5471153, at *5 ("In this case . . . Plaintiff does not bring a cause of action based on the federal FDCA or NLEA but rather based on state laws; as such, the Pom Wonderful holding is inapplicable as to whether section 337(a) preempts the claims based upon California state law."); In Re Farm Raised Salmon Cases, 42 Cal. 4th 1077, 1084 n.5 (2008) ("There is no dispute that, under California law, private parties may assert UCL claims based on violations of the Sherman Law."). "[T]he state duties in such a case 'parallel' rather than add to, federal requirements." Reigel v. Medtronic, Inc., 552 U.S. 312, 330 (2008).

Courts in this district generally find express preemption under the FDCA only when: (1) the FDA requirements with respect to a particular food label or package is clear; and (2) the product label or package at issue is compliance with that policy, such that plaintiff necessarily seeks to enforce requirements in excess of what the FDCA, NLEA, and the implementing regulations require. Lam v. General Mills, Inc., 859 F. Supp. 2d 1097, 1102-03 (N.D. Cal. 2012) (finding express preemption where the defendant's uses of the terms "fruit flavored" and "naturally flavored" on fruit snacks were in compliance with FDA regulations); Chacanaca, 752 F. Supp. 2d at 1118-23 (finding express preemption where the defendant's uses of the terms "cholesterol free" and "0g Trans Fat" were in compliance with FDA regulations); Peviani v. Hostess Brands, Inc., 750 F. Supp. 2d 1111, 1119-20 (C.D. Cal. 2010) (finding express preemption where plaintiff's state law claims imposed an obligation for trans fat disclosure that was not required by federal law); Red v. The Kroger Co., No. 10-1025, 2010 WL 4262037, at *4-7 (C.D. Cal Sept. 2, 2010) (finding express preemption where defendant's products were FDA regulations-compliant).

The court first determines whether the labels and packages subject to explicit FDCA and NLEA provisions (and FDA regulations implementing the same) are expressly preempted. These are: (1) the "natural lemon [lemondade] flavor" claims on the Crystal Light products; (2) the "no artificial sweeteners or flavors" claims on the Country Time Pink Lemonade Drink Mix; (3) the nutrient content claims (a) "good source" and "wholesome" on Planter's Nut-trition Wholesome Nut Mix and (b) "with added . . . vitamin D" and "Reduced Fat" on Kraft cheese products; (4) the "sugar free" and "sugarless" claims on various gum and mint products; and (5) slack fill packaging on Easy Mac, Jell-O Sugar Free Strawberry, and Stove Top Cornbread Stuffing Mix.

The court then determines whether (6) the "evaporated cane juice" claims on Back to Nature granola and crackers and (7) the "all natural"-type labels on, inter alia, on Kraft Mexican Style Four Cheese, Back to Nature granola and crackers, and the Crystal Light products are preempted. There are no federal laws or regulations directly on point governing "evaporated cane juice" claims or "all natural" type claims, but the FDA has nevertheless articulated a policy position with respect to each.

1. "Natural lemon [lemonade] flavor" claims

Plaintiff alleges that the "natural lemon [lemonade] flavor with other natural flavor" labels on defendants' Crystal Light products are misleading because the products are "packed with artificial and synthetic chemicals, preservatives and coloring." Opp. Br. 14 (citing AC ¶ 68). FDA regulations expressly govern the use of "natural flavor" labels. Under 21 C.F.R. § 101.22(i)(1), a product may contain a "natural flavor" label even if the product contains artificial, non-flavoring coloring or preservatives, as long as the "characterizing flavor" is, in fact natural. Lam, 859 F. Supp. 2d at 1103 ("So long as that product 'contains natural flavor' which is 'derived from' the 'characterizing food ingredient,' it will not run afoul of the regulation."). Here, defendants' "natural flavor" labels appear to be in compliance with 21 C.F.R. § 101.22(i)(1) because, as defendants' assert and plaintiff does not dispute in the opposition brief, the purchased Crystal Light Products contain a natural characterizing flavor derived from lemon. See 21 C.F.R. § 101.22(a)(3) and § 182.20 ("[N]atural flavor or natural flavoring means the essential oil, oleoresin, essence or extractive, protein hydrolysate, distillate, or any products of roasting, heating or enzymolysis, which contains the flavoring consitutents derived from [lemon or lemon juice].").

Under 21 C.F.R. § 101.22(i)(2), however, if the product contains "any artificial flavor which simulates, resembles or reinforces the characterizing flavor . . . the name of the characterizing flavor shall be accompanied by the words 'artificial' or 'artificially flavored'" (emphasis added). The FDA defines "artificial flavor" in 21 C.F.R. §§ 101.22(a)(1):

The term artificial flavor or artificial flavoring means any substance, the function of which is to impart flavor, which is not derived from a [natural product]. . . . Artificial flavor includes the substances listed in §§ 172.515(b) and 182.60 of this chapter except where these are derived from natural sources.
Although plaintiff does state that certain compounds "provided [the Crystal Light] products with artificial flavor," AC ¶ 68, none of those compounds are actually listed at §§ 172.515(b) and 182.60 as "artificial flavors." Even if these compounds could be artificial flavors, the court need not answer that question because plaintiff does not allege any cognizable claim that these ingredients actually "simulate[], resemble[], or reinforce[] the characterizing [lemon] flavor," which would be necessary to adequately plead any violation of 21 C.F.R. § 101.22(i)(2). See Iqbal, 556 U.S. at 678 ("The plausibility standard . . . asks for more than a sheer possibility that a defendant has acted unlawfully."); Twombly, 550 U.S. at 561 ("Factual allegation must be enough to raise a right to relieve above the speculative level."). Moreover, at oral argument, the plaintiff's counsel focused their argument exclusively on the presence of unnatural ingredients generally, rather than unnatural flavors, making it clear to the court that plaintiff did not even intend to plead a violation of 21 C.F.R. § 101.22(i)(2). This case is like Lam, where "[t]he crux of the []AC is that the [products'] labeling is deceptive because the products' ingredients, not their flavors, are unnatural." 859 F. Supp. 2d at 1102 (emphasis added). The Lam court held that such allegations were insufficient to state any violation of the FDA regulations because "a product may be labeled as 'fruit flavored' or 'naturally flavored,' even if it does not contain fruit or natural ingredients . . . [s]o long as that product 'contains natural flavor' which is 'derived from' the 'characterizing food ingredient.'" Id. at 1102-03. Because there is no dispute here that the lemon flavor in the Crystal Light product is a natural flavor under the regulations, the natural lemon flavor labels are in compliance with FDA regulation. Like in Lam, plaintiff's claims concerning the "natural lemon flavor" labels are preempted by the FDCA, see id. at 1103, and dismissed with leave to amend.

2. "No artificial sweeteners or flavors"

Plaintiff alleges that she relied on unlawful and deceptive "no artificial sweetneners or flavors" labels in purchasing Country Time Pink Lemonade Drink Mix. According to plaintiff, the drink mix contains maltodextrin, an artificial sweetner, and sodium citrate, an artificial flavoring agent, and thus the "no artificial" labels are false and misleading. See Cal. Health & Safety Code § 110740 (which mirrors 21 U.S.C. § 343(k), requiring any product that "bears or contains any artificial flavoring, artificial coloring, or chemical preservatives . . . [to] bear[] labeling stating that fact"); AC ¶ 85. Defendants counter that these claims are expressly preempted because, under FDA regulations, maltodextrin is not a sweetener and sodium citrate is not a flavoring agent, and thus the labels comply with all FDA regulations on point. Defendants rely on: (1) 21 C.F.R. § 184.1444, which defines "maltodextrin" as "a nonsweet nutritive saccharide polymer"; and (2) the FDA's "Listing of Specific Substances Affirmed as [Generally Recognized as Safe ("GRAS")], which defines "sodium citrate" as "the sodium salt of citric acid," 21 C.F.R. § 184.1751, and "citric acid" as "a naturally occurring consitutent of plant and animal tissues." 21 C.F.R. § 184.1033.

The FDA's definitions of maltodextrin and sodium citrate in the list of GRAS substances do not exclude the possibility that these ingredients could be used in the drink mix at issue as sweetening or flavoring agents, which would require disclosure under California Health & Safety Code § 110740. Similar to the "natural flavor" anlaysis supra, the factual determinations of whether maltodextrin is used as a sweetener and/or sodium citrate is used as a flavoring agent in this particular product, and whether a reasonable consumer would have thus been misled by the "no artificial sweeteners or preservatives" label, are inappropriate for determination on a motion to dismiss. Because defendant does not seek to impose any requirements in excess 21 U.S.C. § 343(k), the claims based on "no artificial sweeteners or flavors" labels on the challenged drink mix are not preempted and survive the motion to dismiss.

3. Nutrient content claims

Plaintiff alleges that the nutrient content claims (a) "good source" and "wholesome" on Planter's Nut-rition Wholesome Nut Mix and (b) "with added . . . vitamin D" and "reduced fat" on Kraft cheese products are unlawful and misleading nutrient content claims under California law. See, e.g., Cal. Health & Safety Code § 110665 (which incorporates by reference 21 U.S.C. § 343(r) (nutrient content claims) and the regulations implemented thereto); AC ¶¶ 119, 125. Defendants counter that these claims are in compliance with the FDA regulations governing nutrient content claims, and thus plaintiff's claims seeking more are expressly preempted.

a. "Good source" and "wholesome"

Plaintiff alleges that the "good source of 5 vitamins and minerals" and "wholesome" labels on Platner's Nut-rition Wholesome Nut Mix are unlawful because, although the product admittedly does bear the required referral statement disclosing fat content pursuant to 21 C.F.R. §§ 101.13(h)(1), that statement "[i]s inadequate as it [i]s nearly invisible due to its font size, placement and contrasting background color." AC ¶ 133. Upon apparently realizing that the product at issue does, in fact, contain the required referral statement, in the opposition brief, plaintiff now makes the hyper-technical argument that the referral statements on the packaging violate 21 C.F.R. §§ 101.13(h)(4)(i) and (ii), which respectively require that the referral statement: (1) "be in easily legible boldface print or type" and (2) "immediately adjacent to the nutrient content claim" on each panel of the label bearing the nutrient content claim. There is no specific allegation in the AC, however, establishing non-compliance with either of these regulations. In evaluating whether plaintiff has stated a claim, the court is limited to the pleadings, and "may not look beyond the complaint to a plaintiff's moving papers, such as a memorandum in opposition to a defendant's motion to dismiss." Schneider v. Cal. Dep't of Corrections, 151 F.3d 1194, 1197 n.1 (9th Cir. 1998) (emphasis in original). Because the products at issue contain the required referral statement, they comply with FDA regulations in this regard, and are thus expressly preempted by the NLEA.

b. "With added. . . vitamin D" and "reduced fat"

Plaintiff alleges that the "with added . . . vitamin D" and "reduced fat" labels on Kraft's Mexican Style Four Cheese and Kraft Deli Deluxe Cheese products are unlawful for failure to include the required disclosure statement of: "See nutrition information for fat content" (required when the fat content per reference amount exceeds 13.0 grams of fat or 4.0 grams of saturated fat). 21 C.F.R. § 101.13(h)(1). The Kraft Mexican Style Four Cheese Blend does, in fact, contain the required referral statement. Reply, Ex. A. For the same reasons discussed above, plaintiffs do not sufficiently plead any claim for a violation of the FDA's prominence and placement requirements for referral statements. Accordingly, the Kraft Mexican Style Four Cheese Blend complies with FDA regulations and plaintiff's claims based on this product are expressly preempted. With respect to the Deli Deluxe cheese product, however, which does not contain the required referral statement, plaintiff seeks nothing more than the FDA regulation, 21 C.F.R. § 101.13(h), requires, and the court cannot dismiss the claims based on the Kraft Deli Deluxe label at this stage.

4. "Sugar Free" claims

Plaintiff alleges that the "sugar free" and "sugarless" claims on the challenged gum and mint products are unlawful and misleading because they are not accompanied by the required disclosures for products that contain 0.5 grams or more of sugar per reference amount. See 21 C.F.R. § 101.60(c)(1)(iii)(A) (requiring either "low calorie" or "reduced calorie" labels or that the product "bears a claim of special dietary usefulness"); id. § 101.60(c)(1)(iii)(B) (requiring that the "sugar free" term, each time it is used, be accompanied with: "'not a reduced calorie food,' 'not a low calorie food,' or 'not for weight control.'"); AC ¶¶ 153-60. To the extent the challenged products do contain disclosures pursuant to § 101.60(c)(1)(iii)(B), plaintiff alleges that those disclosures do not comply with 21 C.F.R. § 101.2(b). This section provides that claims of dietary usefulness under "Subpart D of section 101," which includes 21 C.F.R. § 101.60, "shall appear either on the principal display panel or on the information panel, unless otherwise specified by regulations in this chapter." Plaintiff explicitly alleges non-compliance with the prominence and placement requirements of these regulations. AC ¶¶ 155, 159-61. Again, compliance with this regulation is a factual issue inappropriate for resolution on a motion to dismiss on the pleadings, and plaintiff seeks to impose nothing more than the FDA requirements. Accordingly, the court cannot dismiss the claims based on unlawful "sugar free" and "sugarless" labels at this stage.

5. Slack fill packaging

Plaintiff alleges that she relied on unlawful and deceptive slack fill packaging in purchasing Easy Mac, Jell-O Sugar Free Strawberry, and Stove Top Cornbread Stuffing Mix. Defendants counter that express preemption applies because plaintiff fails to allege that these slack fill packages actually violate FDA policy, which permits functional slack fill packaging. In contrast to defendants' assertion, plaintiff does allege that the slack fill packaging was unlawful. AC ¶¶ 192-93 ("Defendants routinely employed slack filled packaging to mislead consumers" and "lacked any lawful justification for doing so."). Because plaintiff does not ask the court to require anything different than the FDA requirements, specifically 21 C.F.R. ¶ 100.100, see AC ¶ 191, the claims relying on unlawful slack fill packaging are not preempted.

6. "Evaporated cane juice"

Plaintiff alleges that the Back to Nature granola and crackers at issue contain misleading "evaporated cane juice" claims. Plaintiff argues that, according to the FDA's published policy, "evaporated cane juice" is merely a type of sugar, and as such, it is false and misleading to characterize it as a type of "juice."

In 2009, the FDA published a document titled "Draft Guidance for the Industry: Ingredients Declared as Evaporated Cane Juice" informing the industry:

The intent of this draft guidance is to advise the regulated industry of FDA's view that the term "evaporated cane juice" is not the common or usual name of any type of sweetener, including dried cane syrup. Because cane syrup has a standard of identity defined by regulation in 21 CFR 168.130, the common or usual name for the solid or dried form of cane syrup is "dried cane syrup.
Sweeteners derived from sugar cane syrup should not be listed in the ingredient declaration by names which suggest that the ingredients are juice, such as "evaporated cane juice." FDA considers such representations to be false and misleading under section 403(a)(1) of the Act (21 U.S.C. 343(a)(1)) because they fail to reveal the basic nature of the food and its characterizing properties (i.e., that the ingredients are sugars or syrups) as required by 21 CFR 102.5.
2009 WL 3288507 (Oct. 2009). The FDA's position is thus clear that it considers "evaporated cane juice" labels to be "false and misleading" under 21 U.S.C. 343(a)(1). Defendants' argument that this FDA document "do[es] not establish legally enforceable responsibilities," Mot. 23 (citing the draft guidance), while correct, is inapposite because this claim can nevertheless go forward at this early stage under the "deceptive" prong of the UCL. The FDA's 2009 industry guidance statement is relevant to the issue of whether these labels could be deceptive or misleading to a reasonable consumer, and there is no risk of undermining the FDA's rulemaking expertise in allowing a fact finder to make this determination.

7. "Natural" claims

Plaintiff alleges that the "natural cheese" and "100% natural" labels on Kraft Mexican Style Four Cheese and Back to Nature granola and crackers respectively are false and misleading because these products contain numerous artificial ingredients. See AC ¶¶ 67, 87. According to plaintiff, FDA policy is clear that such "natural" labels are misleading where the products, in fact, contain artificial or synthetic ingredients. See 58 Fed. Reg. 2302, 2307 (Jan. 6, 1993) (permitting "natural" labels only when "nothing artificial or synthetic (including all color addities regardless of source) has been included in, or has been added to, a food that would not normally be expected in the food"). Defendants counter that the labels comply with FDA policy and are not plausibly deceptive or misleading to any reasonable consumer.

Numerous courts in this district have rejected the idea that unfair competition claims based on "natural" type labels are expressly preempted by FDA regulations. See Lam, 859 F. Supp. 2d at 1104-05 (rejecting express preemption with respect to "made with real fruit" labels because there was a factual question as to whether a reasonable consumer might be misled by the label); Lockwood, 597 F. Supp. 2d at 1031 (rejecting express preemption and also rejecting field preemption with respect to the use of the term "all natural" because the FDA's decision not to adopt a regulation regarding the use of the term "natural" indicates "an intent not to occupy the field" (emphasis added)); Ben & Jerry's, 2011 WL 2111796, at *10 (rejecting express preemption with respect to the use of the term "natural" where no FDA regulation exists to preempt state law). In 1993, the FDA declined to adopt a specific regulation controlling "natural" labels on foods, and instead stated the following:

After reviewing and considering the comments, the agency continues to believe that if the term "natural" is adequately defined, the ambiguity surrounding use of this term that results in misleading claims could be abated. However, as the comments reflect, there are many facets of this issue that the agency will have to
carefully consider if it undertakes a rulemaking to define the term "natural." Because of resource limitations and other agency priorities, FDA is not undertaking rulemaking to establish a definition for "natural" at this time. The agency will maintain its current policy (as discussed in the general principles proposal (56 FR 60421 at 60466)) not to restrict the use of the term "natural" except for added color, synthetic substances, and flavors as provided in § 101.22. Additionally, the agency will maintain its policy (Ref. 32) regarding the use of "natural," as meaning that nothing artificial or synthetic (including all color additives regardless of source) has been included in, or has been added to, a food that would not normally be expected to be in the food. Further, at this time the agency will continue to distinguish between natural and artificial flavors as outlined in § 101.22.
58 Fed. Reg. 2302, 2407 (1993) (emphases added). Like the analysis supra with respect to "evaporated cane juice" labels, the FDA's position is sufficiently clear with respect to "natural" labels. Whether an ingredient is "artificial or synthetic" under FDA policy is a factual determination on a product-by-product basis. See, e.g., Astiana v. Dryer's Grand Ice Cream Inc., 2012 WL 2990766, at *11 (N.D. Cal. July 20, 2012) (finding a question of fact as to whether a reasonable consumer would normally expect potassium carbonate—an alkalizing agent—to be present in Haagen-Dazs ice cream, based on the FDA's policy statement). Permitting a factual determination to go forward with respect to whether the challenged "natural" labels in this case would deceive a reasonable consumer is not akin to defining FDA policy, but rather is a finding of fact with respect to this particular plaintiff and product, and would not risk undermining the agency's expertise in this area. The court thus denies defendants' motion to dismiss the UCL, FAL and CLRA claims under based on allegedly decpetive "natural" labels.

F. Restitution Based on Unjust Enrichment

"The doctrine [of unjust enrichment] applies where plaintiffs, while having no enforceable contract, nonetheless have conferred a benefit on defendant which defendant has knowingly accepted under circumstances that make it inequitable for the defendant to retain the benefit without paying for its value." Hernandez v. Lopez, 180 Cal. App. 4th 932, 938 (Cal. Ct. App. 2009). Here, plaintiff's claim for unjust enrichment is based on the same allegations as the UCL, FAL and CLRA claims. See AC } 300 ("As a result of Defendants' unlawful, fraudulent and misleading labeling, advertising, marketing and sales of Defendants' Misbranded Food Products, Defendants were enriched at the expense of Plaintiff and the Class."). This claim is simply a reformulation of plaintiff's UCL, FAL and CLRA claims. Restitution is already a remedy under the UCL, so plaintiff's restitution claim is superfluous. Barocio v. Bank of Am., 2012 WL 3945535, at *4 (N.D. Cal. Sept. 10 2012). "[P]laintiff[] cannot assert unjust enrichment claims that are merely duplicative of statutory or tort claims." Id. (quoting In re Apple & AT&T iPad Unlimited Data Plan Litig., 802 F. Supp. 2d 1070, 1077 (N.D. Cal. 2011) (citing cases)). The court, therefore, dismisses the restitution claim without leave to amend.

G. Song-Beverly Consumer Warranty Act

The Song-Beverly Consumer Warranty Act gives the "buyer of consumer goods" a right of action for express warranty violations. Cal. Civ. Code § 1794. The Song-Beverly Act defines an express warranty as "[a] written statement arising out of a sale to the consumer of a consumer good pursuant to which the manufacturer, distributor, or retailer undertakes to preserve or maintain the utility or performance of the consumer good or provide compensation if there is a failure in utility or performance." Cal. Civ. Code § 1791.2. The Act defines a "consumer good" as "any new product or part thereof that is used, bought, or leased for use primarily for personal, family, or household purposes, except for . . . consumables." Id. § 1791(a) (emphasis added). "Consumables" means "any product that is intended for consumption by individuals." Id. § 1791(d). Because plaintiff does not dispute the fact that all products at issue are consumables, and because express warranties under the Act do not apply to consumables, the court dismisses plaintiff's claim under the Song-Beverly Act without leave to amend.

H. Magnuson-Moss Warranty Act Plaintiff's Magnuson-Moss Act claim also fails. The Act defines a written warranty as any written affirmation of fact or written promise made in connection with the sale of a consumer product by a supplier to a buyer which relates to the nature of the material or workmanship and affirms or promises that such material or workmanship is defect free or will meet a specified level of performance over a specified period of time. 15 U.S.C. § 2301(6)(A). Food labels, such as those at issue here, do not constitute warranties against a product defect. See Astiana v. Dreyer's Grand Ice Cream, Inc., 2012 WL 2990766 at *3 (N.D. Cal. July 20, 2012); Jones v. ConAgra Foods, Inc., 2012 WL 6569393, *12-13 (N.D. Cal. Dec. 17, 2012). They "are 'product descriptions' rather than promises that [the products are] defect-free, or guarantees of specific performance levels" over a specified time period. Hairston v. S. Beach Beverage Co., 2012 WL 1893818, at *6 (C.D. Cal. May 18, 2012); see also Skelton v. Gen. Motors Corp., 660 F.2d 311, 316 n.7 (7th Cir. 1981) ("A product information disclosure without a specified time period to which the disclosure relates is . . . not a written warranty."). Since plaintiffs do not allege that the statements on defendants' labels affirm that their products are "defect free," the court dismisses plaintiff's Magnuson-Moss Act claim without leave to amend.

III. ORDER

The court GRANTS defendants' motion to dismiss with prejudice with respect to: (1) plaintiff's restitution claims; (2) the Song-Beverly Act claims; and (3) the Magnuson-Moss Warranty Act claims.

The court GRANTS defendants' motion to dismiss with leave to amend with respect to plaintiffs state law UCL, FAL and CLRA claims based on: (1) any products not purchased by plaintiff ; (2) the "one mint" serving size label; (3) the "natural lemon [lemonade] flavor" labels on defendants' crystal light products; (4) the "good source" and "wholesome" labels on Planter's Nut-rition Wholesome Nut Mix; and (5) the "with added . . . vitamin D" and "reduced fat" labels on Kraft Deli Deluxe Cheese.

The court DENIES defendants' motion to dismiss with respect to the remaining state law UCL, FAL and CLRA claims.

The court hereby sets an initial case management conference for April 19, 2013.

________________________

Ronald M. Whyte

United States District Court Judge


Summaries of

Ivie v. Kraft Foods Global, Inc.

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA SAN JOSE DIVISION
Feb 25, 2013
Case No. C-12-02554-RMW (N.D. Cal. Feb. 25, 2013)

holding that evaporated cane juice claims were not expressly preempted because "the FDA has [] articulated a policy position"

Summary of this case from Werdebaugh v. Growers

holding that ECJ claims were not expressly preempted even though "[t]here are no federal laws or regulations. governing [ECJ] claims. [because] the FDA has nevertheless articulated a policy position"

Summary of this case from Kane v. Chobani, Inc.

In Ivie v. Kraft Foods Global, Inc., the court preempted the plaintiff's consumer protection claims because the plaintiff failed to allege that the artificial substances in the defendant's product—potassium citrate and sodium citrate—functioned as flavors.

Summary of this case from Branca v. BAI Brands, LLC

In Ivie v. Kraft Foods Global, Inc., No. 12-2554, 2013 WL 685372, at *8-9, *12 (N.D. Cal. Feb. 25, 2013) (Whyte, J.), the court held that the evaporated cane juice claim could go forward under the "deceptive" prong of the UCL, because the Draft ECJ Guidance was "relevant to the issue of whether these labels could be deceptive or misleading to a reasonable consumer, and there is no risk of undermining the FDA's rulemaking expertise in allowing a fact finder to make this determination."

Summary of this case from Ross v. Farms
Case details for

Ivie v. Kraft Foods Global, Inc.

Case Details

Full title:SUSAN IVIE, individually and on behalf of all others similarly situated…

Court:UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA SAN JOSE DIVISION

Date published: Feb 25, 2013

Citations

Case No. C-12-02554-RMW (N.D. Cal. Feb. 25, 2013)

Citing Cases

Branca v. BAI Brands, LLC

As such, determining how malic acid (whatever form) should be listed on a product label requires a factual…

Won Kyung Hwang v. OhSo Clean, Inc.

In fact, as several district courts have noted in the wake of Pom, the holding in that case is based not upon…